신수진 (연세대학교 의과대학 강남세브란스병원)님 | 한빛사연구자 > 한빛사

연세대학교 의과대학 강남세브란스병원

최종업데이트 2024.01.24.

Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue Sarcoma
- Clin. Cancer Res., Feb 06 2026, | https://doi.org/10.1158/1078-0432.CCR-25-2633
- 2026-02
- 의약학
- 한빛사논문
Revealing 3D microanatomical structures of unlabeled thick cancer tissues using holotomography and virtual H&E staining
- Nat. Commun., 22 May 2025 | https://doi.org/10.1038/s41467-025-59820-0
- 2025-05
- 바이오·의료융합
- 한빛사논문
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial
- Nat. Commun., 23 January 2024 | https://doi.org/10.1038/s41467-024-44875-2
- 2024-01
- 의약학
- 한빛사논문
Prior antibiotic administration disrupts anti-PD-1 responses in advanced gastric cancer by altering the gut microbiome and systemic immune response
- Cell Rep. Med., October 26, 2023 | https://doi.org/10.1016/j.xcrm.2023.101251
- 2023-10
- 의약학
- 한빛사논문

연구자 ID

저자논문